CTRI/2023/06/054099Not yet recruitingPhase 3
To study the efficacy of Dexmedetomidine as an adjuvant to hyperbaric preparations of 0.5% Levobupivacaine, 0.75% Ropivacaine & 0.5% Bupivacaine in the patients undergoing surgeries under subarachnoid block
Department of Anaesthesia and Critical Care0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Consent from patients and ASA grading I-II posted for lower abdominal and lower limb surgical procedures planned under subarachnoid block.
Exclusion Criteria
- •Non consenting as well pregnant patients, any spinal deformities, infection at the site,uncontrolled co-existing systemic and metabolic diseases, history of alcohol abuse, known sensivity to any LAAs and dexmedetomidine shall be excluded from the study , patients on beta blockers and sinus bradycardia
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effect of dexmedetomidine on eye and venous pressure in patients undergoing elective neurosurgical procedure.CTRI/2021/09/036111Department of anaesthesiology and critical care
Completed
Phase 3
Study to assess the usefulness of a new drug, Dexmedetomidine, for sedation of patients during insertion of a tube in the wind pipe using endoscopy before anaesthesiaCTRI/2012/08/002858Tata Memorial Hospital80
Not yet recruiting
Phase 4
To study the effects of Dexmedetomidine as an adjuvant in attenuating the haemodynamic stress response in patients undergoing laparoscopic surgery under general anesthesiaCTRI/2023/07/055718INDIRA GANDHI MEDICAL COLLEGE
Completed
Phase 1
Evaluation of the efficacy of dexmedetomidine as an anesthetic and effects of spinal cord monitoringSpinal cord tumors, spinal disordersJPRN-UMIN000009044iigata University Medical and Dental Hospital, Anesthesiology10
Not yet recruiting
Phase 3
A clinical trial to study the effect of the drug Dexmedetomidine in controlling agitation which occurs after general anesthesia in oral and nasal surgeriesCTRI/2021/12/038949Karthik